Sagimet Biosciences Inc. (SGMT)

NASDAQ

$9.91

$+1.09

(+12.25%)

Regular Market

Sagimet Biosciences Inc. (SGMT) Live Price Chart

Last updated: ⁦2026-10-20 18:17:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Sagimet Biosciences Inc. (SGMT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $9.91, with a market capitalization of $568.69M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.50 to $11.45. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$568.69M
Open	$8.88
Day's High	$20.71
Day's Low	$1.73
Previous Close	$8.86
Volume	1.48M
Average Volume	1.29M
P/E Ratio	--
52-Week High	$11.45
52-Week Low	$4.50
Dividend Yield	--
Earnings Date	--

Sagimet Biosciences Inc. (SGMT) Stock Price Today

Sagimet Biosciences Inc. (SGMT) is currently trading at $9.91 as of 2026-10-20 18:15:00, up 11.85% ($1.05) from the previous close of $8.86

During today's regular trading session, SGMT has traded between $1.73 and $20.71, with a trading volume of 1.48M shares. The current price is near the middle of today's range.

Sagimet Biosciences Inc. (SGMT) 7-Day Stock Price Change

Over the past seven days, Sagimet Biosciences Inc. (SGMT) moved from $8.93 to $9.91, representing a gain of 10.97% ($0.98).

The stock traded between $7.51 and $10.15 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 1.49 million shares, down versus the previous seven-day period, indicating lower trading activity.

SGMT 52-Week Price Position

Position in Range: 77.9%

52W Low$4.50

52W High$11.45

SGMT is currently trading at $9.91, placing it 77.9% of the way from its 52-week low of $4.50 to its 52-week high of $11.45. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Sagimet Biosciences Inc. (SGMT)?

Sagimet Biosciences Inc a clinical-stage biopharmaceutical company developing novel therapeutics called fatty acid synthase (FASN) inhibitors that target dysfunctional metabolic and fibrotic pathways in diseases resulting from the overproduction of the fatty acid, palmitate. Its drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), acne and select forms of cancer. Its second FASN inhibitor, TVB-3567, is a potent and selective small molecule FASN inhibitor in development for acne. It operates as a single business segment, developing and commercializing therapeutics for the treatment of MASH and other diseases where FASN plays a pathogenic role.

Sagimet Biosciences Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	16
Exchange	NASDAQ
Company Website	https://www.sagimet.com

How to Buy Sagimet Biosciences Inc. (SGMT) Stock on MEXC

Eligible investors can buy real shares of Sagimet Biosciences Inc. (SGMT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for SGMT and Place Your Order

Open the RealStocks trading page and search for SGMT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Sagimet Biosciences Inc. (SGMT) stock price today?

Sagimet Biosciences Inc. (SGMT) is currently trading at $ 9.91, up 11.85% ($1.05) from the previous close of $ 8.86. Intraday prices update in real time during regular trading hours.

2.Is SGMT stock going up or down today?

As of 2026-10-20 18:15:00, SGMT is trading at $ 9.91, up 11.85% ($1.05) from its previous close of $ 8.86. The stock has traded between $ 1.73 and $ 20.71 during today’s regular session. Past price movements do not guarantee future results.

3.What is SGMT pre-market price?

As of 2026-10-20 18:15:00, SGMT is trading at $ 8.72 in pre-market trading, down 1.61% ($0.14) from the previous close of $ 8.86. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is SGMT after-hours price?

As of 2026-10-20 18:15:00, SGMT is trading at $ 8.64 in after-hours trading, down 2.47% ($0.22) from the regular-session close of $ 8.86. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is SGMT stock trading now?

SGMT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does SGMT sit relative to its 52-week high and low?

Over the past 52 weeks, SGMT has traded between a low of $ 4.50 and a high of $ 11.45. At $ 9.91, the stock is positioned 77.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Sagimet Biosciences Inc. in?

Sagimet Biosciences Inc. (SGMT) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Sagimet Biosciences Inc.'s market capitalization and where is it listed?

Sagimet Biosciences Inc. is listed on the NASDAQ exchange with a market capitalization of $ 568.69M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is SGMT valued in terms of P/E ratio and EPS?

SGMT trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.66. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Sagimet Biosciences Inc. pay a dividend?

Sagimet Biosciences Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.